Adenovirus-mediated vascular endothelial growth factor165 gene therapy in treatment of hypoxic-ischemic brain damage: Experiment with rats

National Medical Journal of China

Volumn 89, Issue 2, 2009, Pages 128-132

  Zheng, Xiang Rong ^a   Zhang, Shan Shan ^a   Yin, Fei ^a   Yang, Yu Jia ^a   Zhong, Le ^a   Wang, Xia ^a   Yu, Xiao He ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Gene therapy; Hypoxic ischemic, brain; Vascular endothelial growth factors

Indexed keywords

ADENOVIRUS VECTOR; VASCULOTROPIN; VASCULOTROPIN 165; VASCULOTROPIN A;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN CORTEX; BRAIN DAMAGE; BRAIN HYPOXIA; BRAIN ISCHEMIA; CAROTID ARTERY LIGATION; CONTROLLED STUDY; GENE THERAPY; GENE TRANSFER; HIPPOCAMPUS; IMMUNOCHEMISTRY; NICK END LABELING; NONHUMAN; PROTEIN EXPRESSION; RAT; SENSORIMOTOR FUNCTION; TREATMENT OUTCOME; VIRAL GENE DELIVERY SYSTEM; ADENOVIRUS; ANIMAL; FEMALE; GENETICS; MALE; METABOLISM; SPRAGUE DAWLEY RAT;

ADENOVIRIDAE; ANIMALS; FEMALE; GENE THERAPY; HYPOXIA-ISCHEMIA, BRAIN; MALE; RATS; RATS, SPRAGUE-DAWLEY; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 77954820998     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0376-2491.2009.02.016     Document Type: Article

References (13)

1. Lambrechts D, Carmeliet P. VEGF at the neurovascular interface: therapeutic implications for motor neuron disease. Biochim Biophys Acta, 2006,1762:1109-1121.
2. Meng H, Zhang Z, Zhang R, et al. Biphasic effects of exogenous VEGF on VEGF expression of adult neural progenitors. Neurosci Lett, 2006,393:97-101. (Pubitemid 41821087)
3. Wang Y, Jin K, Mao X, et al. VEGF-overexpressing transgenic mice show enhanced post-ischemic neurogenesis and neuromigration. J Neurosci Res, 2007,85:740-747. (Pubitemid 46426073)
4. Losord DW, Vale PR, Isner JM. Gene therapy for myocardial angiogenesis. Am Heart, 1999,138:132-141.
5. Arreschoug A, Christensen KS. Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation, 1999,99:2967-2968.
6. Hayashi T, Abe K, Itoyama Y. Reduction of ischemic damage by application of vascular endothelial growth factor in rat brain after transient ischemia. J Cereb Blood Flow Metab, 1998,18: 887-895. (Pubitemid 28359907)
7. Storkebaum E, Lambrechts D, Carmeliet P. VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays, 2004,26:943-954. (Pubitemid 39273068)
8. Balduini W, De Angelis V, Mazzoni E, et al. Simvastatin protects against, ischemic brain injury. Stroke, 2001,32:2185-2191.
9. Bona E, Johansson BB, Hagberg H. Sensorimotor function and neuropathology five to six weeks after hypoxia-ischemia in seven-day-old rats. Pediatr Res, 1997,42:678-683. (Pubitemid 27459478)
10. Marti HJ, Bernaudin M, Bellail A, et al. Hypoxia induced vascular endothelial growth factor expression precedes neovascularization after cerebral ischemia. Am J Pathol, 2000, 156:965-976.
11. Sun Y, Jin K, Xie L, et al. Logvinova A, Greenberg DA. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest, 2003,111:1843-1851.
12. Bellomo M, Adamo EB, Deodato B, et al. Enhancement of expression of vascular endothelial growth factor after adeno-associated virus gene transfer is associated with improvement of brain ischemia injury in the gerbil. Pharmacol Res, 2003,48: 309-317.
13. Shen F, Fan Y, Su H, et al. Adeno-associated viral vector-mediated hypoxia-regulated VEGF gene transfer promotes angiogenesis following focal cerebral ischemia in mice. Gene Ther, 2008,15:30-39.